Abstract
BackgroundFN is a serious side-effect of myelotoxic chemotherapy. G-CSF prophylaxis decreases FN incidence and reduces related morbidity and mortality.PurposeEvaluate the budgetary impact of primary (PP) and secondary prophylaxis (SP) of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have